OncoDiag

France
Fresselines, Nouvelle-Aquitaine, France, 27000

Company profile

OncoDiag company profile

OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2012-05-01, Month

Headquarters

Postal code
27000
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$3.7M
Last funding
Series A / $3M / 2021-03-15
Last equity funding
Series A / $3M
Investors
8
Founders
2
Articles
2

Founders and investors

Founders

Claude HennionJean-Pierre Roperch

Investors

AGORANOVAngels SantéBpifranceLes Business Angels des Grandes ÉcolesParis Business Angels